L Catterton Announces Sale of Thorne to The Procter & Gamble Company for $3.8 Billion
The Procter & Gamble Company (NYSE: PG) will acquire Thorne, a science-backed health and wellness brand, from private equity owner L Catterton under a definitive agreement valuing Thorne at $3.8 billion in cash.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
The Procter & Gamble Company (NYSE: PG) will acquire Thorne, a science-backed health and wellness brand, from private equity owner L Catterton under a definitive agreement valuing Thorne at $3.8 billion in cash.
L Catterton invested in Thorne in October 2023 and supported growth by upgrading leadership, marketing, R&D, manufacturing quality systems, and technology, including a proprietary AI wellness advisor. The transaction, with Perella Weinberg Partners and Canaccord Genuity advising Thorne and Jones Day advising Procter & Gamble, is expected to close in the fourth quarter of 2026, subject to customary conditions.
Positive
- $3.8 billion cash acquisition adds established science-backed wellness brand Thorne to PG
- Deal expected to close in Q4 2026, providing a clear near-term timeline
- Acquisition brings Thorne’s 40-year scientific expertise and practitioner relationships into PG’s portfolio
- PG gains access to Thorne’s proprietary AI wellness advisor and enhanced digital capabilities
Negative
- Transaction requires $3.8 billion cash outlay from Procter & Gamble
Details
News Market Reaction – PG
On Aug 4, the day this news came out, PG closed 2.10% above the previous close.
Data tracked by StockTitan Argus for the Aug 4 session.
Key Figures
- Transaction value
- $3.8 billion in cash
- Sale of Thorne to The Procter & Gamble Company
- Investment date
- October 2023
- L Catterton invested in Thorne
- Company history
- 40-year history
- Thorne's scientific expertise and brand development
- Expected closing period
- Fourth quarter of 2026
- Expected transaction closing
- Partnership duration
- Less than three years
- L Catterton's partnership with Thorne
Historical Context
-
Swiffer introduced Lemon Dusters with scent and dust-trapping features.
-
Head & Shoulders activated its multi-year USA Gymnastics partnership.
-
P&G declared a quarterly dividend of $1.0885 per share.
-
Febreze launched a campaign with Major League Soccer and Trevor Noah.
-
P&G scheduled a webcast covering fourth-quarter fiscal 2026 earnings.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
definitive agreement regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
L Catterton's Deep Category Conviction and Brand Vision Allowed for Accelerated Growth and Fortified Thorne's Position as the Premier Trusted Brand in Science-Backed Wellness
L Catterton invested in Thorne in October 2023 following years of research into the Vitamins, Minerals, and Supplements (VMS) category, recognizing an enduring shift in consumer behavior toward proactive, clinical-based products and an integrative approach to self-directed care. The firm's conviction that consumers would increasingly seek trusted solutions to support overall health and longevity led it to identify Thorne as the best-positioned brand to meet this consumer demand.
L Catterton helped accelerate Thorne's next phase of growth by recruiting an exceptional leadership team, expanding the brand's reach through enhanced marketing and commercial capabilities, further investing in science and R&D, strengthening world-class manufacturing and quality systems, and building technology and data infrastructure that enabled the Company to better serve practitioners and consumers. Given Thorne's 40-year history of scientific expertise, practitioner relationships, and consumer insights, the Company developed a proprietary AI wellness advisor that educates and enhances the consumer experience. In less than three years, the partnership further strengthened Thorne's leadership in wellness while preserving the scientific rigor and product quality that have defined the brand since its founding.
Marc Magliacano, a Managing Partner at L Catterton, said, "Our investment in Thorne reflects what L Catterton does best: identifying enduring shifts in consumer behavior and partnering with category-leading brands to help them realize their full potential. As consumers increasingly prioritize proactive, clinically-backed solutions that increase healthspan, we believed Thorne was uniquely positioned to lead the category. We are proud to have partnered with the Company during this important chapter in its growth and are confident it is well positioned for all that is ahead."
Rajan Shah, a Partner at L Catterton, added, "From the outset, we shared a long-term vision with Colin and the Thorne team to build on the brand's strong foundation and the trust it had earned with practitioners and consumers alike, while accelerating its next phase of growth. It was a privilege to partner with such an exceptional management team, and we are confident Procter & Gamble is best positioned to build on that momentum."
Colin Watts, Chief Executive Officer of Thorne, said, "L Catterton has been an outstanding partner over the past several years. They shared our long-term vision for Thorne, investing in our people, strengthening our capabilities across digital, AI, and supply chain, and advancing our scientific rigor, world-class manufacturing, quality standards, and innovation that define Thorne – all while helping us better serve healthcare practitioners and customers. I'm incredibly proud of what we've accomplished together and grateful for the role they played in helping prepare Thorne for this next chapter."
The transaction is expected to close in the fourth quarter of 2026. Perella Weinberg Partners and Canaccord Genuity LLC acted as financial advisors to Thorne, and Kirkland & Ellis served as legal advisor. Jones Day acted as legal advisor to Procter & Gamble.
About L Catterton
L Catterton is the largest global consumer-focused investment firm managing approximately
CONTACT
Julie Hamilton
media@lcatterton.com
View original content:https://www.prnewswire.com/news-releases/l-catterton-announces-sale-of-thorne-to-the-procter--gamble-company-for-3-8-billion-302842797.html
SOURCE L Catterton
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.